Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol DAB2IP contributors: mct/pgu - updated : 13-02-2010
HGNC name DAB2 interacting protein
HGNC id 17294
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • N-terminus containing the C2 and GAP domains constitutively binds to MAP3K5 and facilitating the release of 14-3-3 from MAP3K5
  • one PH domain and one FLR motif
  • a proline-rich region (amino acids 796-807) critical for maintaining DAB2IP in a closed form, which associates with a region of TNFR1 distinct from the death domain, the site of TNFR1 association with TRADD
  • C terminal leucine zipper domain
  • HOMOLOGY
    interspecies homolog to rattus Dip1/2
    intraspecies homolog to RASA1
    Homologene
    FAMILY
  • RAS GTPase activating protein family
  • CATEGORY regulatory , tumor suppressor
    SUBCELLULAR LOCALIZATION     plasma membrane
        intracellular
    intracellular,cytoplasm,organelle,mitochondria
    intracellular,cytoplasm,organelle,membrane
    intracellular,nucleus
    basic FUNCTION
  • mediating TNF-alpha-induced ASK1 activation by facilitating dissociation of inhibitor 14-3-3 from MAP3K5, a novel mechanism by which TNF-alpha activates MAP3K5
  • transducer in TNF-induced TRAF2-dependent activation of MAP3K5 that mediates a balance between JNK versus NF-kappaB signaling
  • being essential for transducing the IRE1-mediated ER stress response
  • potent growth inhibitor by inducing G0/G1 cell cycle arrest and is proapoptotic in response to stress
  • can coordinate PI3K-Akt inactivation with ASK1 activation pathways
  • unique scaffold protein to balance pathways of cell proliferation, survival, and death
  • functions as a scaffold protein in regulating epithelial-to-mesenchymal transition by modulating nuclear beta-catenin/T-cell factor activity
  • ; suppress cell survival and proliferation through suppression of the PI3K-Act and RAS pathways and to induce apoptosis through activation of MAP3K5, a member of the JNK and MAPK14 pathways
  • endogenous inhibitor of KDR-mediated signaling, an important regulator of angiogenesis control (
  • GTPase activating protein that binds to Disabled-1, a cytosolic adapter protein involved in Reelin signaling and brain development
  • plays an important role in dendrite development and regulates the number of synapses in the cerebellum
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein
  • DAB2
  • MAP3K5
  • cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --low  
    in prostate cancer
    tumoral fusion translocation    
    fused with MLL in t(9;11) (q34;q23) in acute myeloid leukemia
    tumoral        
    leads to imbalance of cell survival and apoptosis pathways, which plays a significant role in tumor development
    Susceptibility
  • to aggressive prostate cancer
  • to early onset myocardial infarction, peripheral arterial disease, abdominal aortic aneurysms and pulmonary embolism
  • Variant & Polymorphism SNP
  • in the DAB2IP gene is associated with risk of aggressive prostate cancer (PCa), and loss of DAB2IP expression is frequently detected in metastatic PCa
  • rs7025486[A] is associated with early onset myocardial infarction, peripheral arterial disease, abdominal aortic aneurysms and pulmonary embolism
  • Candidate gene
    Marker assessment of DAB2IP may provide a prognostic biomarker in prostate carcinoma metastasis
    Therapy target
    SystemTypeDisorderPubmed
    cancermetastases 
    potential therapeutic target for Prostate Carcinoma metastasis
    ANIMAL & CELL MODELS
  • AIP1-deficient mice (AIP1-KO)
  • Dab2IP knock-down mice did not exhibit severe ataxia or cerebellar hypoplasia, but Dab2IP deficiency produced a number of cerebellar abnormalities such as a delay in the development of Purkinje cell (PC) dendrites